Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005930 | axoneme | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: E9ALF3
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 199 | 201 | PF00675 | 0.347 |
CLV_NRD_NRD_1 | 93 | 95 | PF00675 | 0.406 |
DOC_MAPK_gen_1 | 200 | 206 | PF00069 | 0.365 |
DOC_USP7_MATH_1 | 57 | 61 | PF00917 | 0.646 |
LIG_APCC_ABBA_1 | 179 | 184 | PF00400 | 0.449 |
LIG_FHA_1 | 117 | 123 | PF00498 | 0.435 |
LIG_FHA_1 | 176 | 182 | PF00498 | 0.463 |
LIG_FHA_1 | 262 | 268 | PF00498 | 0.517 |
LIG_FHA_1 | 29 | 35 | PF00498 | 0.424 |
LIG_FHA_1 | 3 | 9 | PF00498 | 0.452 |
LIG_FHA_1 | 40 | 46 | PF00498 | 0.461 |
LIG_FHA_1 | 71 | 77 | PF00498 | 0.392 |
LIG_FHA_2 | 146 | 152 | PF00498 | 0.423 |
LIG_LIR_Nem_3 | 143 | 147 | PF02991 | 0.449 |
LIG_LIR_Nem_3 | 176 | 182 | PF02991 | 0.328 |
LIG_LIR_Nem_3 | 218 | 224 | PF02991 | 0.475 |
LIG_LRP6_Inhibitor_1 | 169 | 175 | PF00058 | 0.340 |
LIG_REV1ctd_RIR_1 | 225 | 235 | PF16727 | 0.475 |
LIG_SH2_STAP1 | 183 | 187 | PF00017 | 0.449 |
LIG_SH2_STAT5 | 138 | 141 | PF00017 | 0.344 |
LIG_SH2_STAT5 | 205 | 208 | PF00017 | 0.344 |
LIG_SH3_3 | 4 | 10 | PF00018 | 0.556 |
LIG_SH3_3 | 40 | 46 | PF00018 | 0.524 |
LIG_SUMO_SIM_par_1 | 30 | 35 | PF11976 | 0.417 |
LIG_SUMO_SIM_par_1 | 72 | 77 | PF11976 | 0.480 |
MOD_CK1_1 | 238 | 244 | PF00069 | 0.464 |
MOD_CK1_1 | 60 | 66 | PF00069 | 0.679 |
MOD_CK2_1 | 140 | 146 | PF00069 | 0.363 |
MOD_GlcNHglycan | 187 | 190 | PF01048 | 0.437 |
MOD_GlcNHglycan | 237 | 240 | PF01048 | 0.432 |
MOD_GlcNHglycan | 261 | 264 | PF01048 | 0.473 |
MOD_GlcNHglycan | 34 | 37 | PF01048 | 0.487 |
MOD_GlcNHglycan | 76 | 79 | PF01048 | 0.465 |
MOD_GSK3_1 | 238 | 245 | PF00069 | 0.382 |
MOD_GSK3_1 | 28 | 35 | PF00069 | 0.541 |
MOD_GSK3_1 | 66 | 73 | PF00069 | 0.512 |
MOD_GSK3_1 | 74 | 81 | PF00069 | 0.471 |
MOD_N-GLC_1 | 47 | 52 | PF02516 | 0.553 |
MOD_N-GLC_1 | 78 | 83 | PF02516 | 0.409 |
MOD_NEK2_1 | 140 | 145 | PF00069 | 0.475 |
MOD_NEK2_1 | 227 | 232 | PF00069 | 0.413 |
MOD_NEK2_1 | 242 | 247 | PF00069 | 0.243 |
MOD_NEK2_1 | 39 | 44 | PF00069 | 0.526 |
MOD_NEK2_1 | 47 | 52 | PF00069 | 0.502 |
MOD_NEK2_2 | 118 | 123 | PF00069 | 0.363 |
MOD_PIKK_1 | 145 | 151 | PF00454 | 0.398 |
MOD_PKA_1 | 185 | 191 | PF00069 | 0.398 |
MOD_PKA_2 | 259 | 265 | PF00069 | 0.268 |
MOD_PKB_1 | 173 | 181 | PF00069 | 0.437 |
MOD_Plk_1 | 175 | 181 | PF00069 | 0.399 |
MOD_Plk_1 | 215 | 221 | PF00069 | 0.398 |
MOD_Plk_1 | 39 | 45 | PF00069 | 0.437 |
MOD_Plk_1 | 47 | 53 | PF00069 | 0.387 |
MOD_Plk_1 | 78 | 84 | PF00069 | 0.413 |
MOD_Plk_2-3 | 192 | 198 | PF00069 | 0.330 |
MOD_Plk_4 | 2 | 8 | PF00069 | 0.601 |
MOD_Plk_4 | 269 | 275 | PF00069 | 0.519 |
MOD_Plk_4 | 28 | 34 | PF00069 | 0.483 |
MOD_Plk_4 | 66 | 72 | PF00069 | 0.515 |
TRG_DiLeu_BaEn_4 | 40 | 46 | PF01217 | 0.508 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IL58 | Leptomonas seymouri | 55% | 99% |
A0A0S4KFM6 | Bodo saltans | 38% | 100% |
A0A1X0P907 | Trypanosomatidae | 48% | 100% |
A0A3Q8IDZ0 | Leishmania donovani | 94% | 100% |
A0A422NEU4 | Trypanosoma rangeli | 47% | 100% |
A4HHS8 | Leishmania braziliensis | 82% | 100% |
A4I4X9 | Leishmania infantum | 93% | 100% |
C9ZKL1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 45% | 100% |
E9AED3 | Leishmania major | 94% | 100% |
V5C239 | Trypanosoma cruzi | 48% | 100% |